Selected article for: "comparable level and severe group"
Author: Jing Liu; Sumeng Li; Jia Liu; Boyun Liang; Xiaobei Wang; Hua Wang; Wei Li; Qiaoxia Tong; Jianhua Yi; Lei Zhao; Lijuan Xiong; Chunxia Guo; Jin Tian; Jinzhuo Luo; Jinghong Yao; Ran Pang; Hui Shen; Cheng Peng; Ting Liu; Qian Zhang; Jun Wu; Ling Xu; Sihong Lu; Baoju Wang; Zhihong Weng; Chunrong Han; Huabing Zhu; Ruxia Zhou; Helong Zhou; Xiliu Chen; Pian Ye; Bin Zhu; Shengsong He; Yongwen He; Shenghua Jie; Ping Wei; Jianao Zhang; Yinping Lu; Weixian Wang; Li Zhang; Ling Li; Fengqin Zhou; Jun Wang; Ulf Dittmer; Mengji Lu; Yu Hu; Dongliang Yang; Xin Zheng
Title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
  • Document date: 2020_2_18
    • ID: 9xmeyrtu_12
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.16.20023671 doi: medRxiv preprint 1 compared to those of the mild patients. The difference was significant at the time point of disease onset and became even greater on 4-6 days later ( Figure 1C ). From 7-15 days after disease onset, the lymphocyte counts gradually increased in the severe group, and reached a comparable level to that of .....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.02.16.20023671 doi: medRxiv preprint 1 compared to those of the mild patients. The difference was significant at the time point of disease onset and became even greater on 4-6 days later ( Figure 1C ). From 7-15 days after disease onset, the lymphocyte counts gradually increased in the severe group, and reached a comparable level to that of the mild patients at 16 days after disease onset ( Figure 1C ). No significant differences in monocyte counts were observed between the two groups during the whole observation period ( Figure 1D ).

    Search related documents:
    Co phrase search for related documents
    • comparable level and mild patient: 1
    • comparable level and mild patient comparable level: 1
    • comparable level and severe group: 1
    • comparable level and significant difference: 1, 2
    • disease onset and gradually severe group increase: 1
    • disease onset and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease onset and mild patient: 1, 2, 3, 4, 5, 6, 7, 8
    • disease onset and monocyte count: 1, 2
    • disease onset and observation period: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • disease onset and severe group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease onset and severe group increase: 1, 2
    • disease onset and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease onset and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • disease onset time point and severe group: 1
    • disease onset time point and significant difference: 1
    • disease onset time point and time point: 1, 2, 3, 4, 5, 6
    • gradually severe group increase and severe group: 1
    • gradually severe group increase and severe group increase: 1
    • gradually severe group increase and time point: 1